{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T19:00:08Z","timestamp":1777748408399,"version":"3.51.4"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T00:00:00Z","timestamp":1538784000000},"content-version":"vor","delay-in-days":278,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Reports"],"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/j.toxrep.2018.10.006","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T00:24:26Z","timestamp":1539044666000},"page":"1011-1013","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Cefotaxime induced generalized bullous fixed drug eruption - A case report"],"prefix":"10.1016","volume":"5","author":[{"given":"R.","family":"Manikandan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Porselvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.C.","family":"Keerthana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Vaishnavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Girija","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murali","family":"Narasimhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TM.","family":"Vijayakumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.toxrep.2018.10.006_bib0005","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0190-9622(03)01588-3","article-title":"Specific site involvement in fixed drug eruption","volume":"49","author":"Ozkaya-Bayazit","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"issue":"4","key":"10.1016\/j.toxrep.2018.10.006_bib0010","first-page":"744","article-title":"Bullous fixed drug eruption to ciprofloxacin: a case report","volume":"7","author":"Jain","year":"2013","journal-title":"J. Clin. Diagn. Res."},{"issue":"3","key":"10.1016\/j.toxrep.2018.10.006_bib0015","first-page":"201","article-title":"Fixed drug eruption: a disease mediated by self-inflicted responses of intraepidermal T cells","volume":"17","author":"Shiohara","year":"2007","journal-title":"Eur. J. Dermatol."},{"issue":"4","key":"10.1016\/j.toxrep.2018.10.006_bib0020","doi-asserted-by":"crossref","first-page":"608","DOI":"10.2165\/00003495-199040040-00008","article-title":"Cefotaxime. An update of its pharmacology and therapeutic use","volume":"40","author":"Todd","year":"1990","journal-title":"Drugs"},{"key":"10.1016\/j.toxrep.2018.10.006_bib0025","series-title":"Melmon and Morrelli\u2019s Clinical Pharmacology","year":"1992"},{"issue":"5","key":"10.1016\/j.toxrep.2018.10.006_bib0030","doi-asserted-by":"crossref","first-page":"643","DOI":"10.4103\/0253-7613.100403","article-title":"Fixed drug eruption to fluconazole: a case report and review of literature","volume":"44","author":"Pai","year":"2012","journal-title":"Indian J. Pharmacol."},{"key":"10.1016\/j.toxrep.2018.10.006_bib0035","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.jaad.2012.08.019","article-title":"Oral mucosal fixed drug eruption: characteristics and differential diagnosis","volume":"69","author":"\u00d6zkaya","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.toxrep.2018.10.006_bib0040","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.aller.2011.10.004","article-title":"Fixed drug eruption due to norfloxacin and cross\u2011reactivity with other quinolones","volume":"41","author":"S\u00e1nchez-Morillas","year":"2013","journal-title":"Allergol. Immunopathol. (Madr.)"},{"key":"10.1016\/j.toxrep.2018.10.006_bib0045","doi-asserted-by":"crossref","first-page":"8771","DOI":"10.3892\/mmr.2017.7746","article-title":"Staphylococcus aureus colonisation in patients from a primary regional hospital","volume":"16","author":"Ungureanu","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"2","key":"10.1016\/j.toxrep.2018.10.006_bib0050","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3892\/mmr.2016.6034","article-title":"Antimicrobial resistance development following surgical site infections","volume":"15","author":"Calina","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"11","key":"10.1016\/j.toxrep.2018.10.006_bib0055","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1046\/j.1365-4362.1998.00451.x","article-title":"Haroon. Drugs causing fixed eruptions: a study of 450 cases","volume":"37","author":"Mahboob","year":"1998","journal-title":"Int. J. Dermatol."},{"issue":"September (3)","key":"10.1016\/j.toxrep.2018.10.006_bib0060","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00404-004-0698-7","article-title":"Chemoprophylactic and bactericidal efficacy of 80 mg gentamicin in a single and once-daily dosing","volume":"272","author":"Sifakis","year":"2005","journal-title":"Arch. Gynecol. Obstet."},{"issue":"5","key":"10.1016\/j.toxrep.2018.10.006_bib0065","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2165\/00128071-200809050-00011","article-title":"Ceftriaxone induced fixed drug eruption: first report","volume":"9","author":"Ozkaya","year":"2008","journal-title":"Am. J. Clin. Dermatol."},{"issue":"2","key":"10.1016\/j.toxrep.2018.10.006_bib0070","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin. Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.toxrep.2018.10.006_bib0075","first-page":"2765","article-title":"Causality, severity and preventability assessment of adverse cutaneous drug reaction: a prospective observational study in a tertiary care hospital","volume":"7","author":"Padmavathi","year":"2013","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.toxrep.2018.10.006_bib0080","unstructured":"The use of the WHO-UMC system for standardised case causality assessment. Available from: http:\/\/www.who.int\/medicines\/areas\/quality_safety\/safety_efficacy\/WHOcausality_assessment.pdf. (Last Accessed on 01 October 2018)."}],"container-title":["Toxicology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750018303032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750018303032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T15:47:37Z","timestamp":1762012057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214750018303032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":16,"alternative-id":["S2214750018303032"],"URL":"https:\/\/doi.org\/10.1016\/j.toxrep.2018.10.006","relation":{},"ISSN":["2214-7500"],"issn-type":[{"value":"2214-7500","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cefotaxime induced generalized bullous fixed drug eruption - A case report","name":"articletitle","label":"Article Title"},{"value":"Toxicology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxrep.2018.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}